Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like

• US 10,201,660 B2
• Filed: 11/25/2013
• Issued: 02/12/2019
• Est. Priority Date: 11/30/2012
• Status: Active Grant

• Current Assignee: SiO2 Medical products Inc.
• Original Assignee: SiO2 Medical products Inc.
• Inventors: Weikart, Christopher, Clark, Becky L., Stevenson, Adam, Abrams, Robert S., Belfance, John, Jones, Joseph A., Fisk, Thomas E.
• Primary Examiner(s): Sellman, Cachet I
• Application Number:
  US14/647,189
• Publication Number:
  US 20150335823A1
• Time in Patent Office: 1,905 Days
• Field of Search: None
• CPC Class Codes: A61M 2005/3131 specially adapted for improving sealing or sliding
• CPC Class Codes: A61M 2205/0222 Materials for reducing friction
• CPC Class Codes: A61M 2205/0238 the material being a coating or protective layer
• CPC Class Codes: A61M 2207/00 Methods of manufacture, assembly or production
• CPC Class Codes: A61M 2207/10 Device therefor
• CPC Class Codes: A61M 5/3129 Syringe barrels A61M5/3205 and A61M5/50 take precedence
• CPC Class Codes: A61M 5/31513 Piston constructions to improve sealing or sliding
• CPC Class Codes: C23C 16/045 Coating cavities or hollow spaces, e.g. interior of tubes; Infiltration of porous substrates
• CPC Class Codes: C23C 16/401 containing silicon
• CPC Class Codes: C23C 16/505 using radio frequency discharges
• CPC Class Codes: C23C 16/52 Controlling or regulating the coating process C23C16/45557, C23C16/279 take precedence

Abstract

A method and apparatus for plasma modifying a workpiece such as a medical barrel, medical barrel, vial, or blood tube is described. Plasma is provided within the lumen of the workpiece. The plasma is provided under conditions effective for plasma modification of a surface of the workpiece. A magnetic field is provided in at least a portion of the lumen. The magnetic field has an orientation and field strength effective to improve the uniformity of plasma modification of the generally cylindrical interior surface 16 of the generally cylindrical interior surface 16.

Claims

1. A medical syringe barrel or medical cartridge barrel comprising:

a wall having a generally cylindrical interior surface defining at least a portion of a lumen, the generally cylindrical interior surface having an inside diameter of 4 to 15 mm and the aspect ratio between the length and inside diameter of the generally cylindrical interior surface subjected to PECVD is from 2 to 10; and

a PECVD set of one or more plasma enhanced chemical vapor deposition coatings or layers on at least a portion of the generally cylindrical interior surface, the PECVD set comprising;

a barrier coating or layer having a mean thickness from 10 to 500 nm with a standard deviation less than the mean thickness; and

a pH protective coating or layer between the barrier coating or layer and the lumen, in which a Fourier transform infrared spectroscopy (FTIR) absorbance spectrum of the pH protective coating or layer has a ratio greater than 0.75 and at most 1.7 between;

the maximum amplitude of the Si—

O—

Si symmetrical stretch peak between about 1000 and 1040 cm<sup>−

1</sup>, and

the maximum amplitude of the Si—

O—

Si asymmetric stretch peak between about 1060 and about 1100 cm<sup>−

1</sup>.

2. The medical syringe barrel or medical cartridge barrel of claim 1, in which the medical syringe barrel or medical cartridge barrel has an attached hypodermic needle, the generally cylindrical surface having a needle end, a back end, and a body portion between the ends.

3. The medical syringe barrel or medical cartridge barrel of claim 1, in which the standard deviation is at least 20% of the mean thickness.

4. The medical syringe barrel or medical cartridge barrel of claim 1, made of COC (cyclic olefin copolymer), COP (cyclic olefin polymer), PET (polyethylene terephthalate), polypropylene, polycarbonate, polystyrene, polymethylmethacrylate, glass, or a combination of two or more of these.

5. The medical syringe barrel or medical cartridge barrel of claim 1, in which the barrier coating or layer consists essentially of SiO_x, in which x is from 1.5 to 2.9 as determined by X-ray photoelectron spectroscopy (XPS).

6. The medical syringe barrel or medical cartridge barrel of claim 1, in which the oxygen barrier improvement factor of the wall and PECVD set, compared to the wall without the PECVD set, is from 5 to 12.

7. The medical syringe barrel or medical cartridge barrel of claim 1, further comprising a closure seated to the medical barrel to form a closed lumen, in which the lumen has a volume between 0.5 and 50 ml and the inward oxygen transmission rate through the wall and the PECVD set is from 0.0012 to 0.00048 cubic cm per package per day, at 20°

C., at atmospheric pressure outside the wall.

8. The medical syringe barrel or medical cartridge barrel of claim 1, in which the PECVD set is effective to maintain an oxygen barrier improvement factor, versus a barrel without the PECVD set, of at least 5 and at most 31 after the PECVD set is stored in contact with U.S. Pharmacopeia Water for Injection having a pH of 7.0 for a period of three months at a temperature of 25°

C.

9. The medical syringe barrel or medical cartridge barrel of claim 1, further comprising a fluid composition in the lumen having a pH between 4 and 9 and a closure retaining the fluid composition in the lumen, defining a fluid storage package.

10. The medical syringe barrel or medical cartridge barrel of claim 1, wherein the medical syringe barrel or medical cartridge barrel is made of transparent material.

11. The medical syringe barrel or medical cartridge barrel of claim 1, wherein the medical syringe barrel or medical cartridge barrel is made of injection moldable thermoplastic material.

12. The medical syringe barrel or medical cartridge barrel of claim 1, wherein the medical syringe barrel or medical cartridge barrel is made of COC (cyclic olefin copolymer), COP (cyclic olefin polymer), PET (polyethylene terephthalate), polypropylene, polycarbonate, polystyrene, polymethylmethacrylate, glass, or a combination of two or more of these.

13. The medical syringe barrel or medical cartridge barrel of claim 1, in which the pH protective coating or layer consists essentially of SiO_xC_y, in which x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, each as measured by XPS.

14. The medical syringe barrel or medical cartridge barrel of claim 1, in which the pH protective coating or layer consists essentially of the following atomic ratios of silicon, oxygen, and carbon as determined by X-ray photoelectron spectroscopy, and atomic ratio of hydrogen as determined by Rutherford backscattering spectrometry:

15. The medical syringe barrel or medical cartridge barrel of claim 1, in which the pH protective coating or layer has a mean thickness from 50 to 500 nm.

16. The medical syringe barrel or medical cartridge barrel of claim 1, further comprising a tie coating or layer consisting essentially of SiO_xC_y, in which x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, each as measured by XPS.

17. The medical syringe barrel or medical cartridge barrel of claim 16, in which the tie coating or layer consists essentially of the following atomic ratios of silicon, oxygen, and carbon as determined by X-ray photoelectron spectroscopy, and atomic ratio of hydrogen as determined by Rutherford backscattering spectrometry:

18. The medical syringe barrel or medical cartridge barrel of claim 1, in which the PECVD set is effective to maintain an oxygen barrier improvement factor, versus a barrel without the PECVD set, of at most 31 after the PECVD set is stored in contact with U.S. Pharmacopeia Water for Injection having a pH of 7.0 for a period of three months at a temperature of 25°

C.

19. The medical syringe barrel or medical cartridge barrel of claim 1, in which the PECVD set further comprises a tie coating or layer between the barrier coating or layer and the generally cylindrical interior surface, in which the tie coating or layer has a mean thickness from greater than 0 to 10 nm.

20. A syringe comprising a medical syringe barrel or medical cartridge barrel of claim 1.

21. A medical syringe barrel or medical cartridge barrel comprising:

a wall having a generally cylindrical interior surface defining at least a portion of a lumen, the generally cylindrical interior surface having an inside diameter of 4 to 15 mm; and

a PECVD set of one or more plasma enhanced chemical vapor deposition coatings or layers on at least a portion of the generally cylindrical interior surface, the PECVD set comprising;

a barrier coating or layer having a mean thickness from 10 to 500 nm with a standard deviation less than the mean thickness;

a pH protective coating or layer between the barrier coating or layer and the lumen, in which a Fourier transform infrared spectroscopy (FTIR) absorbance spectrum of the pH protective coating or layer has a ratio greater than 0.75 and at most 1.7 between;

the maximum amplitude of the Si—

O—

Si symmetrical stretch peak between about 1000 and 1040 cm<sup>−

1</sup>, and

the maximum amplitude of the Si—

O—

Si asymmetric stretch peak between about 1060 and about 1100 cm<sup>−

1</sup>; and

a tie coating or layer between the barrier coating or layer and the generally cylindrical interior surface, in which the tie coating or layer has a mean thickness from greater than 0 to 10 nm.

22. A cartridge comprising a medical syringe barrel or medical cartridge barrel of claim 21.

23. A medical syringe barrel or medical cartridge barrel comprising:

a wall having a generally cylindrical interior surface defining at least a portion of a lumen, the generally cylindrical interior surface having an inside diameter of 4 to 15 mm; and

a PECVD set of one or more plasma enhanced chemical vapor deposition coatings or layers on at least a portion of the generally cylindrical interior surface, the PECVD set comprising;

a barrier coating or layer having a mean thickness from 10 to 500 nm with a standard deviation from 190 to 10 nm; and

a pH protective coating or layer between the barrier coating or layer and the lumen, in which a Fourier transform infrared spectroscopy (FTIR) absorbance spectrum of the pH protective coating or layer has a ratio greater than 0.75 between;

the maximum amplitude of the Si—

O—

Si symmetrical stretch peak between about 1000 and 1040 cm<sup>−

1</sup>, and

the maximum amplitude of the Si—

O—

Si asymmetric stretch peak between about 1060 and about 1100 cm<sup>−

1</sup>.

24. The medical syringe barrel or medical cartridge barrel of claim 23, in which the standard deviation of the mean barrier coating or layer thickness is from 160 to 20 nm.

25. The medical syringe barrel or medical cartridge barrel of claim 23, in which the standard deviation of the mean barrier coating or layer thickness is from 140 to 20 nm.

26. The medical syringe barrel or medical cartridge barrel of claim 23, in which the standard deviation of the mean barrier coating or layer thickness is from 120 to 50 nm.